← Eichor
Study identifier: NCT07391241 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)

Condition: Vulvodynia  ·  Sponsor: Initiator Pharma

PhasePhase 2
Planned participants24
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

The study (IP2015CS05) is a randomised, double-blind, placebo-controlled, 4-way cross-over trial studying the efficacy and safety of single dose administration of pudafensine in vulvodynia (provoked vestibulodynia) patients.

This description comes directly from the study's public registry record.

Talk to the study team

Abimbola Babajide, Dr, MBCHB  ·  +44 01253444451  ·  abimbolababajide@macplc.com

Always discuss trial participation with your own doctor first.

Locations (1)

MACBlackpool, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07391241